ConductScience.org, home

Paper41879751

Methylphenidate Treatment and Risk of Psychotic Disorder.

Healy C and 14 others. JAMA Psychiatry, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Methylphenidate Treatment and Risk of Psychotic Disorder. Papers, record 41879751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41879751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Methylphenidate Treatment and Risk of Psychotic Disorder.
PubMed
Journal
JAMA Psychiatry
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Healy CColm
2O'Hare KKirstie
3Lång UUlla
4Metsälä JJohanna
5Pulakka AAnna
6McGrath JJane
7Migone MMaria
8Keating DDolores
9Romaniuk LLiana
10Gyllenberg DDavid
11Kajantie EEero
12Perrett GGeorge
13Hill JJennifer
14Elwert FFelix
15Kelleher IIan

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MethylphenidateMajor topic
Attention Deficit Disorder with HyperactivityMajor topic
Psychotic DisordersMajor topic
Central Nervous System StimulantsMajor topic
Humans
Female
Male
Adolescent
Child
Finland
Registries
Cohort Studies

Source PubMed

Download CSV of topics

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
121163621Use of instrumental variable in prescription drug research with observational data: a systematic review.J Clin Epidemiol2011https://conductscience.org/library/papers/21163621PubMed
233625499Association of Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence With the Risk of Subsequent Psychotic Disorder: A Systematic Review and Meta-analysis.JAMA Psychiatry2021https://conductscience.org/library/papers/33625499PubMed
322510277Comparison of instrumental variable analysis using a new instrument with risk adjustment methods to reduce confounding by indication.Am J Epidemiol2012https://conductscience.org/library/papers/22510277PubMed
438639006Mendelian randomization: causal inference leveraging genetic data.Psychol Med2024https://conductscience.org/library/papers/38639006PubMed
540900605Occurrence of Psychosis and Bipolar Disorder in Individuals With Attention-Deficit/Hyperactivity Disorder Treated With Stimulants: A Systematic Review and Meta-Analysis.JAMA Psychiatry2025https://conductscience.org/library/papers/40900605PubMed
634079068Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies.Mol Psychiatry2022https://conductscience.org/library/papers/34079068PubMed
722899561Quality of the Finnish Hospital Discharge Register: a systematic review.Scand J Public Health2012https://conductscience.org/library/papers/22899561PubMed
828658489Association of Electroconvulsive Therapy With Psychiatric Readmissions in US Hospitals.JAMA Psychiatry2017https://conductscience.org/library/papers/28658489PubMed
937742289Effect of ADHD medication on risk of injuries: a preference-based instrumental variable analysis.Eur Child Adolesc Psychiatry2024https://conductscience.org/library/papers/37742289PubMed
1025998281Is Adult ADHD a Childhood-Onset Neurodevelopmental Disorder? Evidence From a Four-Decade Longitudinal Cohort Study.Am J Psychiatry2015https://conductscience.org/library/papers/25998281PubMed
1131570648Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.Pediatrics2019https://conductscience.org/library/papers/31570648PubMed
1229744873Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies.Cochrane Database Syst Rev2018https://conductscience.org/library/papers/29744873PubMed
1326399420Demographic Characteristics and Psychiatric Comorbidity of Children and Adolescents Diagnosed with ADHD in Specialized Healthcare.Child Psychiatry Hum Dev2016https://conductscience.org/library/papers/26399420PubMed
1433520751
Hallucinations and other psychotic symptoms in response to methylphenidate in children and adolescents with attention-deficit/hyperactivity disorder: a Cochrane systematic review with meta-analysis and trial sequential analysis.
Scand J Child Adolesc Psychiatr Psychol2018https://conductscience.org/library/papers/33520751PubMed
1526363968Attention-deficit/hyperactivity disorder, methylphenidate use and the risk of developing schizophrenia spectrum disorders: A nationwide population-based study in Taiwan.Schizophr Res2015https://conductscience.org/library/papers/26363968PubMed
1630893533Psychosis with Methylphenidate or Amphetamine in Patients with ADHD.N Engl J Med2019https://conductscience.org/library/papers/30893533PubMed
1737385582Effect of Pharmacological Treatment of Attention-Deficit/Hyperactivity Disorder on Criminality.J Am Acad Child Adolesc Psychiatry2024https://conductscience.org/library/papers/37385582PubMed
1811322741Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters.J Child Adolesc Psychopharmacol2001https://conductscience.org/library/papers/11322741PubMed
1916319382Risk of death in elderly users of conventional vs. atypical antipsychotic medications.N Engl J Med2005https://conductscience.org/library/papers/16319382PubMed
2035027679The effects of stimulant dose and dosing strategy on treatment outcomes in attention-deficit/hyperactivity disorder in children and adolescents: a meta-analysis.Mol Psychiatry2022https://conductscience.org/library/papers/35027679PubMed

See all 39 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 0 citations.

PMIDTitleJournalYearIn PapersSource
42875515Attention deficit hyperactivity disorder: transition to psychotic disorders.Mol Psychiatry2026https://conductscience.org/library/papers/42875515PubMed
42585902Negative symptom dimensions link cognitive impairment to global and social functioning in 22q11.2 deletion syndrome.Schizophr Res2026https://conductscience.org/library/papers/42585902PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41879751

GET https://conductscience.org/api/papers/v1/41879751/references?page=2